COMMUNIQUÉS West-GlobeNewswire

Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
14/08/2026
Quarter highlighted by steadily increasing patient demand for Vivos’ differentiated array of highly effective OSA treatments Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., Aug. 14, 2026 (GLOBE [...]
Profound Medical Announces Management Change
14/08/2026
TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI ( [...]
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
14/08/2026
Advancing tivoxavir marboxil toward MHRA resubmission in Q3 2026 with a revised toxicology package, supporting initiation of the Phase 2a human influenza Challenge study Completed the April 2026 private placement and [...]
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
14/08/2026
WATERTOWN, Mass., Aug. 14, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, [...]
PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027
14/08/2026
MINNEAPOLIS, MN, US, Aug. 14, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV), in cooperation with its wholly owned subsidiaries, Cosmeta Corp, PetVivo Animal Health, Inc. and PetVivo AI, Inc., a leading [...]
Optimi Health Establishes Discretionary Equity Facility
14/08/2026
VANCOUVER, British Columbia, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “ Company ” or “ Optimi ”), a commercial-stage pharmaceutical manufacturer of regulated [...]
Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
14/08/2026
Acquisition of Kira Pharmaceuticals closed in July creating a combined company with a robust portfolio of clinical stage assets focused on immunologically-driven disorders Completed a concurrent PIPE financing raising $ [...]
Sierra Donor Services New Mexico Honors Local Donor Heroes During National Multicultural Donor Awareness Month
14/08/2026
ALBUQUERQUE, N.M., Aug. 14, 2026 (GLOBE NEWSWIRE) -- During the month of August, Sierra Donor Services New Mexico recognizes National Multicultural Donor Awareness Month by honoring the diverse donor heroes in the state [...]
Sierra Donor Services Honors Local Donor Heroes During National Multicultural Donor Awareness Month
14/08/2026
SACRAMENTO, Calif., Aug. 14, 2026 (GLOBE NEWSWIRE) -- During the month of August, Sierra Donor Services (SDS) and Donate Life California recognize National Multicultural Donor Awareness Month by honoring the diverse [...]
Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
14/08/2026
SAN DIEGO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (Nasdaq: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world [...]
A Race Against Blindness Launches Luxury Ford F-250 Fundraising Drive to Cure Childhood Blindness
14/08/2026
2026 Ford F-250 Super Duty King Ranch and $40,000 cash headline the charity’s latest fundraiser to end childhood blindness GILBERT, Ariz., Aug. 14, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness announced the launch [...]
Indiana Center for Recovery Named No. 1 Addiction Treatment Center in Indiana by Newsweek
14/08/2026
Indiana Center for Recovery in Bloomington ranks top in the state on Newsweek’s 2026 list for excellence in addiction treatment and mental health services. BLOOMINGTON, Ind., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Indiana [...]
Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update
14/08/2026
Completed acquisition of Orphai Therapeutics, adding LAM-001, an inhaled formulation of rapamycin for the treatment of multiple serious, underserved pulmonary diseases, to pipeline LAM-001 Phase 2b data in PH-ILD [...]
Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update
14/08/2026
TUDRIQEV™ in combination with nivolumab receives FDA accelerated approval and will launch within 60 days Michelle DiNapoli appointed as Chief Commercial Officer Recently completed financing extends cash runway to [...]
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
14/08/2026
Pivotal Phase 3 Alzheimer’s disease (AD) trial is fully enrolled with a total number of 850 patients, exceeding original projections. Parkinson’s disease (PD) open-label extension (OLE) study has enrolled 266 patients [...]
GT Biopharma Reports Second Quarter 2026 Financial Results
14/08/2026
Phase 1 trial evaluating GTB-3650 TriKE ® remains ongoing, with an update anticipated in 2H 2026 Phase 1 basket trial evaluating GTB-5550 TriKE ® in multiple solid tumor types known to express B7-H3 initiated May 2026 [...]
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights
14/08/2026
Enrollment of platinum-resistant/refractory ovarian cancer patients for the primary analysis in the Phase 2 monotherapy portion of the PYNNACLE clinical trial completed Rezatapopt NDA submission for platinum-resistant/ [...]
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
14/08/2026
- Completed quarter with $26.9 million in cash and restricted cash - Key U.S. patent was awarded, protecting exclusivity of stenoparib when used with the stenoparib-specific DRP ® companion diagnostic into 2042 - AACR [...]
Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026
14/08/2026
COPENHAGEN, Denmark, August 14, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will provide a business update and [...]

Pages